Provided by Tiger Fintech (Singapore) Pte. Ltd.

LIFECORE BIOMEDICAL INC

7.76
+0.03000.39%
Post-market: 8.250.4900+6.31%18:34 EDT
Volume:143.00K
Turnover:1.10M
Market Cap:287.32M
PE:-5.20
High:7.86
Open:7.79
Low:7.49
Close:7.73
Loading ...

Lifecore Biomedical Q4 EPS $(0.06) Beats $(0.10) Estimate, Sales $36.444M Beat $35.363M Estimate

Benzinga
·
4 hours ago

Lifecore Biomedical Inc - Expects $74-$76 Mln Revenue for Remainder of 2025

THOMSON REUTERS
·
4 hours ago

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
4 hours ago

Lifecore Biomedical Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
06 Aug

Craig-Hallum Sticks to Its Buy Rating for Lifecore Biomedical (LFCR)

TIPRANKS
·
05 Aug

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

GlobeNewswire
·
01 Aug

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
18 Jul

Craig-Hallum Reaffirms Their Buy Rating on Lifecore Biomedical (LFCR)

TIPRANKS
·
09 Jul

Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)

TIPRANKS
·
17 Jun

Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer

MT Newswires Live
·
17 Jun

Lifecore signs new 10-year commercial manufacturing, supply agreement

TIPRANKS
·
17 Jun

Craig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)

TIPRANKS
·
12 Jun

Press Release: Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Dow Jones
·
12 Jun

Aron R. English, 10% Owner, Reports Disposal of Lifecore Biomedical Inc. Common Shares

Reuters
·
29 May

Press Release: Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Dow Jones
·
27 May

Lifecore Biomedical Initiated at Outperform by William Blair

Dow Jones
·
22 May

Lifecore initiated with an Outperform at William Blair

TIPRANKS
·
21 May

William Blair Initiates Coverage on Lifecore Biomedical With Outperform Rating

MT Newswires Live
·
21 May

Aron English, 10% Owner, Reports Disposal of Common Shares of Lifecore Biomedical Inc

Reuters
·
16 May

Aron English, 10% Owner, Reports Disposal of Common Shares in Lifecore Biomedical Inc

Reuters
·
13 May